Harlan M Krumholz
Harlan M Krumholz
One-Year Results from a Multi-Center Trial of a Polymer Surgical Mitral Valve: Insights into New Technology [0.03%]
一种新型生物聚合物材质二尖瓣修复器的多中心临床试验一年结果及其意义
Isaac George,Dasari Prasada Rao,Anil Jain et al.
Isaac George et al.
Background: Polymer leaflet material may extend the durability of surgical mitral valve replacement (SMVR) to provide stable long-term hemodynamics. The India Mitral Surgical Trial sought to evaluate the safety and perfor...
Marc Gillinov,Tarek Malas,Milind Y Desai et al.
Marc Gillinov et al.
Michael A Borger,Mateo Marin-Cuartas
Michael A Borger
Aortic Stenosis and Mitral Regurgitation: Takeaways From the Heart Valve Collaboratory Workshop on Multivalvular Disease [0.03%]
主动脉瓣狭窄和二尖瓣反流：多瓣膜疾病协作研讨会的收获
Syed Zaid,Vivian Ng,Rebecca T Hahn et al.
Syed Zaid et al.
The management of multivalvular disease presents increasing challenges in clinical practice caused by complex hemodynamic interactions and limited guideline-based recommendations. As part of the inaugural collaboration between JACC and the ...
Renate Schoenenberger-Berzins,Franz H Messerli
Renate Schoenenberger-Berzins
Reply: Tirzepatide in Obesity-Related Heart Failure With Preserved EF: Weight Loss and Structural Adaptations [0.03%]
回复： tirzepatide在与肥胖相关的射血分数保留型心力衰竭中的应用：体重减轻和结构适应性变化
Christopher M Kramer,Barry A Borlaug,Michael R Zile et al.
Christopher M Kramer et al.
Tirzepatide in Obesity-Related Heart Failure With Preserved EF: Weight Loss and Structural Adaptations [0.03%]
tirzepatide在肥胖相关射血分数保留的心力衰竭中的应用：体重减轻和结构适应性变化
Laurent Fauchier,Lisa Lochon,Thibault Lenormand
Laurent Fauchier
Correction [0.03%]
改正
A Year of Listening [0.03%]
倾听的一年
Harlan M Krumholz
Harlan M Krumholz